Ontario Partners With Biolab Pharma To Open Production Hub In Mississauga
10/20/2017
Biolab Pharma develops, manufactures and commercializes prescription medicine and is a leader in cardiology and dermatology drugs. It is one of the ten largest pharmaceutical companies in Brazil.
With support from Ontario's Jobs and Prosperity Fund, the company is retrofitting a 13,000 square foot research development and innovation facility in Mississauga. It will also invest in new equipment and special software to improve its research capabilities. Ontario officials said enhancements will help the company develop and commercialize innovative products for the North American and European markets.
“We are pleased to partner with the Ontario government on this exciting initiative as we expand our operations internationally. Our new facility will help us sharpen our competitive edge and better serve our customers by continually improving and creating innovative products,” Cleiton de Castro Marques, CEO, Biolab Pharma Ltd.
Strengthening Ontario's life sciences sector is part of our plan to create jobs, grow our economy and help people in their everyday lives, a Provincial spokesperson said. Ontario is the largest life sciences jurisdiction in Canada with more than 50 per cent of the country’s total life sciences economic activity. Ontario’s life sciences sector employs approximately 60,000 people. Ontario is investing up to $2.8 million through the Jobs and Prosperity Fund for this project. This is part of a larger overall investment by the company valued at $57.4 million. The project is scheduled for completion in December 2022.
“Our government is excited that Biolab Pharma chose Ontario for its first international site. Today’s announcement is a testament to the province’s competitive and innovative life sciences sector and highly skilled workforce. This is an excellent example of how strategic partnerships can help drive economic growth and create high value jobs in the province,” Brad Duguid, Minister of Economic Development and Growth said.
“Ontario’s private sector is at the forefront of economic growth, tapping into our highly skilled workforce to fill the jobs of tomorrow. Through the Jobs and Prosperity Fund alone, businesses have created or retained more than 35,000 jobs, including 40 announced today at Biolab Pharma. These partnerships contribute to the strong and sustained growth of the Ontario economy, with over 794,500 net new jobs created since the recession. We are proud that our strategic investments are helping businesses across Ontario grow and prosper, Charles Sousa, Minister of Finance, added.
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024